We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AMGXF market cap is 66.57M. The company's latest EPS is JPY -37.4630 and P/E is -0.01.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 326.76M | 40M | 64.15M | 67.06M | 152.99M |
| Operating Income | -3.27B | -6.53B | -15.61B | -16.42B | -11.96B |
| Net Income | -3.75B | -4.21B | -13.68B | -14.71B | -7.44B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 12.52B | 38.35B | 45.46B | 38.82B | 28.89B |
| Total Liabilities | 469.25M | 5.67B | 6.82B | 8.4B | 2.79B |
| Total Equity | 12.06B | 32.68B | 38.63B | 30.43B | 26.1B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | -2.18B | -2.96B | -11.38B | -11.21B | -8.75B |
| Investing | -1.25B | -6.96B | -154.87M | -97.14M | -356.65M |
| Financing | 7.68B | 11.4B | 17.38B | 3.57B | 2.04B |
| Market Cap | 66.57M |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0.44 |
| Price to Cash Ratio | 0.02 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 198.53M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 2.06k |
| 52 Week Change | -55.29% |
| 52 Week High | 1.00 |
| 52 Week Low | 0.3353 |
| Spread (Intraday) | 0.06 (16.53%) |
| Company Name | Anges Inc (PK) |
| Address |
1f, saito bio-incubator ibaraki, osaka 567-0085 |
| Website | https://www.anges-mg.com |
| Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
